Precigen Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Thanks again for tuning into the JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst. Our next presenting company is Precigen, and it's my pleasure to welcome and introduce President and CEO Helen Sabzevari, to tell us a little bit about the company. (Operator Instructions) Helen, thanks, for sharing some of your time with us this afternoon.
Thank you so much, Eric, and thank you for the opportunity to present at the 39th Annual JPMorgan Healthcare Conference. And I also want to -- hope that all of our listeners and their families are safe and healthy as we begin 2021.
Before I start the presentation, I also want to remind everyone, I will be making some forward-looking statements, which please pay attention to the slides that it's in Slide #2. With that in mind, I think we should start and going to Slide #3.
What I really want to touch base today is, first of all, get
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |